Demographic and socioeconomic disparities of benign cerebral meningiomas in the United States. (April 2021)

• Record Type: Journal Article
• Authors: Ghaffari-Rafi, Arash; Mehdizadeh, Rana; Ko, Andrew Wai Kei; Ghaffari-Rafi, Shadeh; Leon-Rojas, Jose
• Is Part Of: Journal of clinical neuroscience. Volume 86(2021)
• Page Start: 122
• Page End: 128
• Publication Date: 2021-04
• Subjects: BCM Benign Cerebral Meningiomas -- US United States -- CNS Central Nervous System -- NIS National (Nationwide) Inpatient Sample -- HCUP Healthcare Cost and Utilization Project -- ICD-9-CM ICD-10-CM International Classification of Diseases 9th or 10th edition Clinical Modification -- WHO World Health Organization -- HIS Indian Health Services; Benign meningiomas -- Socioeconomic -- Demographics -- Disparities -- Incidence -- United States -- Income; Brain -- Surgery -- Periodicals; Neurosciences -- Periodicals; Nervous system -- Surgery -- Periodicals; Brain -- surgery -- Periodicals; Neurosurgical Procedures -- Periodicals; Neurosciences -- Periodicals; Electronic journals; 616.8
• DOI: 10.1016/j.jocn.2021.01.023
• Languages: English
• ISSNs: 0967-5868

Abstract

Highlights: United States median annual 1997–2016 benign cerebral meningioma (BCM) incidence was 5.01 (per 100, 000) and increasing. Female incidence between 1997 and 2016 was larger than male incidence. Middle/high income patients had a larger incidence that low income patients. Patients living in rural communities had a higher incidence than those in suburban or urban areas. Whites had the largest incidence amongst compared race/ethnicity groups. Abstract: Epidemiology provides an avenue for deciphering disease pathogenesis. By determining incidence across socioeconomic and demographic variables in the context of benign cerebral meningiomas (BCM), epidemiologic data may aid in elucidating and addressing healthcare inequalities. To investigate BCM incidence (per 100, 000) with respect to sex, age, income, residence, and race/ethnicity, we queried the largest United States (US) administrative dataset (1997–2016), the National (Nationwide) Inpatient Sample (NIS), which surveys 20% of US discharges. Annual national BCM incidence was 5.01. Females had an incidence of 6.78, higher (p = 0.0000038) than males at 3.14. Amongst age groups incidence varied (p = 1.65 × 10 - 11 ) and was highest amongst those 65–84 (16.71) and 85+ (18.32). Individuals with middle/high income had an incidence of 5.27, higher (p = 0.024) than the 4.91 of low income patients. Depending on whether patients lived in urban, suburban, or rural communities, incidence varied ( χ 2 = 8.22, p = 0.016) as follows, respectively: 5.23; 4.96; 5.51. Amongst race/ethnicity (p = 8.15 × 10 - 14 ), incidence for Whites, Blacks, Asian/Pacific Islanders, Hispanics, and Native Americans were as follows, respectively: 5.05; 4.59; 4.22; 2.99; 0.55. In the US, BCM annual incidence exhibited disparities amongst socioeconomic and demographic subsets. Disproportionately, incidence was greatest for patients who were White, Black, female, 65 and older, and middle/high income.